The Ministry of Health wishes to inform the general public that it will commence introducing the Sinopharm COVID-19 vaccine on Saturday 17th July 2021. Due to the limited stock of this vaccine, Sukuta Health Center, located in Sukuta West Coast Region, has been identified for now, as the only site where one can get vaccinated with Sinopharm vaccine. The vaccine will be given on a first come first have basis, thus individuals should rush to the center on Saturday starting 9am to get their shot. For one to be fully protected with the vaccine, individuals need to receive two doses at an interval of 3 - 4 weeks.
The Ministry would like to remind those who received their first dose of AstraZeneca vaccine that they should not receive a different vaccine apart from AstraZeneca. The Ministry hereby re-assures those who could not get their second eligible dose of AstraZeneca as a result of stock-out, that they will subsequently receive their due dose, as preparations are underway for the availability of more doses of AstraZeneca vaccine.
The public is also reminded that safe and effective vaccination against COVID- 19 is essential to bring this outbreak under control but alone will not be sufficient. observing social distancing, wearing of face mask, avoiding overcrowded places, avoiding handshaking, frequent hand sanitizing and washing hands with soap and clean water are critical intervention strategies.
The Ministry is, therefore, soliciting the continuous support and cooperation of the public in its efforts to contain COVID-19 in the country.
Distributed by APO Group on behalf of Ministry of Health, The Gambia.
© Press Release 2021
Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.
The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.
To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.
